News
4 Mar 2019
Assist in Drug Development of Oligonucleotides
![](/46/pdcnewsitem/07/67/10/yamasa.jpg)
Utilizing our experience of synthesizing various nucleic acid related compounds over 60 years, Yamasa can collaborate in development of new monomers used in drug development of oligonucleotides.
In addition to monomers, Yamasa offers custom synthesis of oligonucleotides.
Mentioned Companies
Yamasa Corporation
![Yamasa Corporation](https://www.cphi-online.com/o6CkeeIyVGQ41TY-comp246884.jpg)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance